摘要
供者缺乏是造血干细胞移植广泛使用的最大障碍。新型移植方案的建立、完善使得单倍体造血干细胞移植成为临床常规, 大量血液病患者得以从中获益, 单倍体供者已经成为中国异基因造血干细胞移植最重要的供者来源。本文聚焦单倍体造血干细胞移植在我国开展的现状及未来发展趋势, 增加临床医师对单倍体造血干细胞移植的了解。
The lack of donors is the biggest obstacle to the widespread use of hematopoietic stem cell transplantation.The establishment and improvement of new transplantation schemes have made haploid hematopoietic stem cell transplantation a clinical routine,benefiting a large number of patients with hematological diseases.Haploid donors have become the most important source of donors for allogeneic hematopoietic stem cell transplantation in China.This article focuses on the current situation and future development trends of haploid hematopoietic stem cell transplantation in China,in order to increase the understanding of clinical doctors on haploid hematopoietic stem cell transplantation.
作者
莫晓冬
黄晓军
Mo Xiaodong;Huang Xiaojun(Peking University People's Hospital&Peking University Institute of Hematology,National Clinical Research Center for Hematologic Disease,Bejing Key Laboratory of Hematopoietic Stem Cell Transplantation,Beijing 100044,China)
出处
《中华血液学杂志》
CAS
CSCD
北大核心
2024年第7期625-628,共4页
Chinese Journal of Hematology
基金
国家重点研发计划(2022YFA1103300、2022YFC2502606)
国家自然科学基金面上项目(82170208)。
